Skip to main content
. 2023 Mar 15;10:1060451. doi: 10.3389/fmed.2023.1060451

Table 3.

Diagnostic performance of the subspecialists for different clinical endpoints.

Subspecialists Sensitivity Specificity PPV NPV
(%; n/N)
95% CI
(%; n/N)
95% CI
(%; n/N)
95% CI
(%; n/N)
95% CI
CIN2+
Senior colposcopist 91.3 (94/103) 46.8 (123/263) 40.2 (94/234) 93.2 (123/132)
84.2–95.3 40.8–52.8 34.1–46.6 87.6–96.4
CAIADS 80.6 (83/103) 63.5 (167/263) 46.4 (83/179) 89.3 (167/187)
71.9–87.1 63.0–71.4 39.2–53.7 84.1–93.0
Junior colposcopist 79.6 (82/103) 48.7 (128/263) 37.8 (82/217) 85.9 (128/149)
70.8–86.3 42.7–54.7 31.6–44.4 79.4–90.6
CAIADS-Junior 95.1 (98/103) 48.3 (127/263) 41.9 (98/234) 96.2 (127/132)
89.1–97.9 42.3–54.3 35.7–48.3 91.4–98.37
CIN3+
Senior colposcopist 90.0 (63/70) 42.2 (125/296) 26.9 (63/234) 94.7 (125/132)
80.7–95.1 36.7–47.9 21.7–33.0 89.5–97.4
CAIADS 80.0 (56/70) 58.4 (173/296) 31.3 (56/179) 92.5 (173/187)
69.2–87.7 52.8–63.9 25.0–38.4 87.8–95.5
Junior colposcopist 85.7 (60/70) 47.0 (139/296) 27.6 (60/217) 93.3 (139/149)
75.7–92.1 41.4–52.7 22.1–34.0 88.1–96.3
CAIADS-Junior 97.1 (68/70) 43.9 (130/296) 29.1 (68/234) 98.5 (130/132)
90.2–99.2 38.4–49.6 23.2–35.2 94.6–99.6
Cancer
Senior colposcopist 91.7 (22/24) 38.0 (130/342) 9.4 (22/234) 98.5 (130/132)
74.2–97.7 33.0–43.3 6.3–13.8 94.6–99.6
CAIADS 100 (24/24) 54.7 (187/342) 13.4 (24/179) 100.0 (187/187)
86.2–100.0 49.4–59.9 9.2–19.2 97.99–100
Junior colposcopist 87.5 (21/24) 42.7 (146/342) 9.7 (21/217) 98.0 (146/149)
69.0–95.7 37.6–48.0 6.4–14.3 94.25–99.31
CAIADS-Junior 95.8 (23/24) 38.3 (131/342) 9.8 (23/234) 99.2 (131/132)
79.8–99.3 33.3–43.6 6.6–14.3 95.8–99.9

CAIADS, Colposcopic Artificial Intelligence Auxiliary Diagnostic System; CAIADS-Junior, CAIADS-assisted junior colposcopist; NPV, negative predictive value; PPV, positive predictive value; CIN, cervical intraepithelial neoplasia; 95% CI, 95% confidence interval; CIN2+, CIN grade 2 or worse; CIN3+, CIN grade 3 or worse; CI: confidence interval.